Literature DB >> 19551908

Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.

Shyam Kottilil1, Michael Y Yan, Kristin N Reitano, Xiaozhen Zhang, Richard Lempicki, Gregg Roby, Marybeth Daucher, Jun Yang, Karoll J Cortez, Marc Ghany, Michael A Polis, Anthony S Fauci.   

Abstract

UNLABELLED: Coinfection with hepatitis C virus (HCV) is present in one-third of all human immunodeficiency virus (HIV)-infected individuals in the United States and is associated with rapid progression of liver fibrosis and poor response to pegylated interferon (IFN) and ribavirin. In this study we examined gene expression profiles in peripheral blood mononuclear cells (PBMCs) from different groups of individuals who are monoinfected or coinfected with HIV and HCV. Data showed that HIV and HCV viremia up-regulate genes associated with immune activation and immunoregulatory pathways. HCV viremia is also associated with abnormalities in all peripheral immune cells, suggesting a global effect of HCV on the immune system. Interferon-alpha-induced genes were expressed at a higher level in PBMCs from HIV-infected individuals. HCV and HIV infections leave distinct profiles or gene expression of immune activation in PBMCs. HIV viremia induces an immune activated state; by comparison, HCV infection induces immunoregulatory and proinflammatory pathways that may contribute to progression of liver fibrosis.
CONCLUSION: An aberrant type-I IFN response seen exclusively in HIV-infected individuals could be responsible for the poor therapeutic response experienced by HIV/HCV coinfected individuals receiving interferon-alpha-based current standard of care.

Entities:  

Mesh:

Year:  2009        PMID: 19551908      PMCID: PMC2736098          DOI: 10.1002/hep.23055

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  46 in total

Review 1.  Chemokines and chemokine receptors in infectious diseases.

Authors:  S Mahalingam; G Karupiah
Journal:  Immunol Cell Biol       Date:  1999-12       Impact factor: 5.126

2.  Concurrent HIV and HCV infections hasten liver failure.

Authors:  M E Eyster
Journal:  Am Fam Physician       Date:  1992-08       Impact factor: 3.292

3.  Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

Authors:  Fabrice Carrat; Firouzé Bani-Sadr; Stanislas Pol; Eric Rosenthal; Françoise Lunel-Fabiani; Asmae Benzekri; Patrice Morand; Cécile Goujard; Gilles Pialoux; Lionel Piroth; Dominique Salmon-Céron; Claude Degott; Patrice Cacoub; Christian Perronne
Journal:  JAMA       Date:  2004-12-15       Impact factor: 56.272

4.  Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000.

Authors:  Mamta K Jain; Daniel J Skiest; Jeff W Cloud; Charu L Jain; Dennis Burns; Ruth E Berggren
Journal:  Clin Infect Dis       Date:  2003-04-02       Impact factor: 9.079

Review 5.  The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.

Authors:  M Zeremski; L M Petrovic; A H Talal
Journal:  J Viral Hepat       Date:  2007-10       Impact factor: 3.728

6.  Elevated serum levels of soluble immune activation markers are associated with increased risk for death in HAART-naive HIV-1-infected patients.

Authors:  Nikolaos V Sipsas; Petros P Sfikakis; Giota Touloumi; Nikos Pantazis; Helen Choremi; Theodore Kordossis
Journal:  AIDS Patient Care STDS       Date:  2003-04       Impact factor: 5.078

7.  The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.

Authors:  Hermann E Wasmuth; Mirko Moreno Zaldivar; Marie-Luise Berres; Alexa Werth; David Scholten; Sonja Hillebrandt; Frank Tacke; Petra Schmitz; Edgar Dahl; Tonio Wiederholt; Claus Hellerbrand; Thomas Berg; Ralf Weiskirchen; Christian Trautwein; Frank Lammert
Journal:  J Hepatol       Date:  2007-11-20       Impact factor: 25.083

Review 8.  Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity.

Authors:  Tatsuya Kanto; Norio Hayashi
Journal:  Intern Med       Date:  2006-03-15       Impact factor: 1.271

9.  Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.

Authors:  Tae-Wook Chun; J Shawn Justement; Richard A Lempicki; Jun Yang; Glynn Dennis; Claire W Hallahan; Christina Sanford; Punita Pandya; Shuying Liu; Mary McLaughlin; Linda A Ehler; Susan Moir; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

10.  Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection.

Authors:  Francesca J Torriani; Ruy M Ribeiro; Tari L Gilbert; Uschi M Schrenk; Marietta Clauson; DeeDee M Pacheco; Alan S Perelson
Journal:  J Infect Dis       Date:  2003-11-13       Impact factor: 5.226

View more
  33 in total

1.  Inteleukin-23 promotes interferon-α responsiveness in hepatitis C virus/HIV-coinfected patients.

Authors:  Madeline Odigie; Anu Osinusi; Lisa Barrett; Kerry Townsend; Honghui Wang; Anthony F Suffredini; Henry Masur; Michael A Polis; Shyam Kottilil
Journal:  AIDS Res Hum Retroviruses       Date:  2014-06-30       Impact factor: 2.205

2.  Systemic cytokine and interferon responsiveness Patterns in HIV and HCV mono and co-infections.

Authors:  Rafael Fernandez-Botran; Swati Joshi-Barve; Smita Ghare; Shirish Barve; Mary Young; Michael Plankey; Jose Bordon
Journal:  J Interferon Cytokine Res       Date:  2014-06-23       Impact factor: 2.607

Review 3.  Substance abuse, HIV-1 and hepatitis.

Authors:  Nirzari Parikh; Michael R Nonnemacher; Vanessa Pirrone; Timothy Block; Anand Mehta; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2012-10       Impact factor: 1.581

4.  Interferon stimulated exonuclease gene 20 kDa links psychiatric events to distinct hepatitis C virus responses in human immunodeficiency virus positive patients.

Authors:  Antonios Katsounas; Joseph J Rasimas; Joerg F Schlaak; Richard A Lempicki; Donald L Rosenstein; Shyam Kottilil
Journal:  J Med Virol       Date:  2014-04-30       Impact factor: 2.327

5.  Chronic immune activation is a distinguishing feature of liver and PBMC gene signatures from HCV/HIV coinfected patients and may contribute to hepatic fibrogenesis.

Authors:  Angela L Rasmussen; I-Ming Wang; Margaret C Shuhart; Sean C Proll; Yudong He; Razvan Cristescu; Chris Roberts; Victoria S Carter; Christopher M Williams; Deborah L Diamond; Janine T Bryan; Roger Ulrich; Marcus J Korth; Lisa V Thomassen; Michael G Katze
Journal:  Virology       Date:  2012-05-16       Impact factor: 3.616

Review 6.  Pathogen-pathogen interaction: a syndemic model of complex biosocial processes in disease.

Authors:  Merrill Singer
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

7.  Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus.

Authors:  Astrid C Frank; Xiaozhen Zhang; Antonios Katsounas; Jennifer P Bharucha; Shyamasundaran Kottilil; Tomozumi Imamichi
Journal:  J Interferon Cytokine Res       Date:  2010-06       Impact factor: 2.607

8.  Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.

Authors:  Damien Sène; Franck Levasseur; Michal Abel; Marion Lambert; Xavier Camous; Céline Hernandez; Véronique Pène; Arielle R Rosenberg; Evelyne Jouvin-Marche; Patrice N Marche; Patrice Cacoub; Sophie Caillat-Zucman
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

9.  High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women.

Authors:  Emmanouil Papasavvas; Lea F Surrey; Deborah K Glencross; Livio Azzoni; Jocelin Joseph; Tanvier Omar; Michael D Feldman; Anna-Lise Williamson; Maureen Siminya; Avril Swarts; Xiangfan Yin; Qin Liu; Cynthia Firnhaber; Luis J Montaner
Journal:  Oncoimmunology       Date:  2016-01-19       Impact factor: 8.110

10.  Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin.

Authors:  Tess Petersen; Yu-Jin Lee; Anu Osinusi; Valerianna K Amorosa; Crystal Wang; Minhee Kang; Roy Matining; Xiao Zhang; Diana Dou; Triin Umbleja; Shyam Kottilil; Marion G Peters
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-14       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.